BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20667468)

  • 1. Alternative ERK5 regulation by phosphorylation during the cell cycle.
    Iñesta-Vaquera FA; Campbell DG; Tournier C; Gómez N; Lizcano JM; Cuenda A
    Cell Signal; 2010 Dec; 22(12):1829-37. PubMed ID: 20667468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisite phosphorylation of Erk5 in mitosis.
    Díaz-Rodríguez E; Pandiella A
    J Cell Sci; 2010 Sep; 123(Pt 18):3146-56. PubMed ID: 20736311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erk5 nuclear location is independent on dual phosphorylation, and favours resistance to TRAIL-induced apoptosis.
    Borges J; Pandiella A; Esparís-Ogando A
    Cell Signal; 2007 Jul; 19(7):1473-87. PubMed ID: 17317102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway.
    Cude K; Wang Y; Choi HJ; Hsuan SL; Zhang H; Wang CY; Xia Z
    J Cell Biol; 2007 Apr; 177(2):253-64. PubMed ID: 17452529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription.
    Honda T; Obara Y; Yamauchi A; Couvillon AD; Mason JJ; Ishii K; Nakahata N
    PLoS One; 2015; 10(2):e0117914. PubMed ID: 25689862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
    Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
    Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
    Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
    Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro.
    Mody N; Campbell DG; Morrice N; Peggie M; Cohen P
    Biochem J; 2003 Jun; 372(Pt 2):567-75. PubMed ID: 12628002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
    Squires MS; Nixon PM; Cook SJ
    Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
    Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
    Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms.
    Kondoh K; Terasawa K; Morimoto H; Nishida E
    Mol Cell Biol; 2006 Mar; 26(5):1679-90. PubMed ID: 16478989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK5 pathway regulates the phosphorylation of tumour suppressor hDlg during mitosis.
    Iñesta-Vaquera FA; Campbell DG; Arthur JS; Cuenda A
    Biochem Biophys Res Commun; 2010 Aug; 399(1):84-90. PubMed ID: 20643107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis.
    Pi X; Yan C; Berk BC
    Circ Res; 2004 Feb; 94(3):362-9. PubMed ID: 14670836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK5: structure, regulation and function.
    Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
    Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
    Tanguay PL; Rodier G; Meloche S
    Biochem J; 2010 Apr; 428(1):103-11. PubMed ID: 20236090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cyclin D1 expression by the ERK5 cascade.
    Mulloy R; Salinas S; Philips A; Hipskind RA
    Oncogene; 2003 Aug; 22(35):5387-98. PubMed ID: 12934098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the Pro-X-Thr-Pro site in phosphatase inhibitor-2 by cyclin-dependent protein kinase during M-phase of the cell cycle.
    Li M; Stefansson B; Wang W; Schaefer EM; Brautigan DL
    Cell Signal; 2006 Aug; 18(8):1318-26. PubMed ID: 16377132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK signalling: ERK5 versus ERK1/2.
    Nishimoto S; Nishida E
    EMBO Rep; 2006 Aug; 7(8):782-6. PubMed ID: 16880823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.